Article
Author(s):
In our “Best of AUA” report, Urology Times’ editors and writers present the AUA annual meeting’s take-home messages in 15 therapeutic areas.
Orlando, FL-The recently concluded AUA annual meeting in Orlando, FL may be best remembered for the lively exchanges of the “Crossfire: Controversies in Urology” sessions. This first-time program saw urology’s thought leaders debate such topics as early detection of prostate cancer, testosterone use/abuse, the use of slings for stress incontinence, and whether percutaneous nephrolithotomy is on the way out.
AUA 2014 was also noteworthy for practical, thought-provoking research on those topics as well as new tests for prostate cancer, prevention of post-prostate biopsy infection, trends in robotic surgery, and use of an advanced prostate cancer agent in the pre-chemotherapy setting.
In our “Best of AUA” report, Urology Times’ editors and writers present the AUA annual meeting’s take-home messages in 15 therapeutic areas. Click on a disease state/category to jump directly to the take homes in that area:
Prostate Cancer, presented by Michael C. Gong, MD, PhD
Basic Science Research, presented by K.C. Balaji, MD
Infection/Inflammation, presented by Dirk Lange, PhD
Infertility/Andrology, presented by Tobias S. Köhler, MD, MPH
Stone Disease/Endourology, presented by Matthew D. Dunn, MD
Transplantation/Vascular Surgery, presented by Jeremy M. Blumberg, MD
Penile, Testis, and Urethral Cancer, presented by Philippe E. Spiess, MD, MS
Trauma/Reconstruction/Diversion, presented by Andrew C. Peterson, MD
Sexual Function/Dysfunction, presented by Landon Trost, MD
Female Urology/Incontinence/Urodynamics, presented by Adonis K. Hijaz, MD
BPH/LUTS, presented by Richard K. Lee, MD, MBA
Minimally Invasive Surgery, presented by Manish A. Vira, MD
Outcomes Analysis, presented by Jesse D. Sammon, DO
Kidney Cancer, presented by Monish Aron, MD
Bladder Cancer, presented by Wassim Kassouf, MD, CM
Subscribe to Urology Times to get monthly news from the leading news source for urologists.